Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2012 USD | -4.82% | -4.14% | -85.10% |
May. 15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.5M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -24M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.53
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.88% |
1 day | -4.82% | ||
1 week | -4.14% | ||
1 month | -18.87% | ||
3 months | -85.10% | ||
6 months | -86.03% | ||
Current year | -85.10% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Litchman
CEO | Chief Executive Officer | 70 | 17-04-23 |
James Murphy
DFI | Director of Finance/CFO | 67 | Jan. 18 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 15-03-12 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.2012 | -4.82% | 6,256,552 |
24-05-30 | 0.2114 | -10.27% | 10,338,876 |
24-05-29 | 0.2356 | +24.99% | 70,847,580 |
24-05-28 | 0.1885 | -10.20% | 13,677,324 |
24-05-24 | 0.2099 | -3.27% | 6,113,611 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.10% | 2.5M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MBIO Stock